Editor's Note This case-controlled study by researchers from White River Junction Veterans Affairs Medical Center, White River Junction, Vermont, and Dartmouth School of Medicine, Hanover, New Hampshire, finds that mRNA vaccine effectiveness against COVID-19 decreases significantly after about 6 months. In this analysis of 14,238 male veterans aged 65 or…

Read More

Editor's Note On December 1, the first case of COVID-19 attributed to the Omicron variant was reported in the US, according to the Centers for Disease Control and Prevention (CDC). As of December 8, Omicron variant cases had been reported in 22 states, including some that indicated community transmission. Of…

Read More

Editor's Note In this study, researchers from Stanford University School of Medicine find that the initial COVID-19 shutdown from March through April 2020 resulted in a decrease in surgical volume to nearly half of baseline rates. After the reopening, surgical volume rebounded to 2019 levels, and the trend was maintained.…

Read More

Editor's Note The Centers for Disease Control and Prevention, on December 1, issued a statement that the California and San Francisco Departments of Public Health have confirmed that a recent case of COVID-19 in an individual in California was caused by the Omicron variant (B.1.1.529). The individual, who has mild…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC), on November 2, recommended broad use of the Pfizer/BioNTech COVID-19 vaccine for children ages 5 to 11. Distribution of the vaccine to clinics, children’s hospitals, and pediatricians’ offices across the country have started, with plans to scale up to full…

Read More

Editor's Note In an October 26 news release, ECRI announced the publication of a Position Statement on “COVID-19 Vaccines: Mitigating Disease and Promoting Global Health Equity.” Speaking in support of the Statement, Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI, says: “Despite the FDA and CDC’s advancement of…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) director Rochelle P. Walensky, MD, MPH, on October 21, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation for a booster of COVID-19 vaccines in certain populations. For individuals who received Pfizer-BioNTech or Moderna COVID-19 vaccines, the following are eligible…

Read More

Editor's Note This study by researchers at Yale University School of Medicine, New Haven, Connecticut, identifies three themes centered on trust and addressing barriers to COVID-19 vaccine access in Black and Latinx communities in the US. The study involved 72 participants—56 women, 16 men, 36 Black, 28 Latinx, and 8…

Read More

Editor's Note The Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH) is seeking comments on workplace and occupational safety and health interventions to prevent work-associated stress, support stress reduction, and foster positive mental health and well-being among healthcare workers. Examples of interventions include employee…

Read More

Editor's Note This study from the Centers for Disease Control and Prevention finds that the percentage of US adults with anxiety and depression symptoms increased nationwide during the COVID-19 pandemic (August 19, 2020 to June 7, 2021). Using US Census Bureau Household Pulse Survey (HPS) data, the CDC found that…

Read More